Welcome to the Prostate Cancer Treatment Center

We are pleased to announce the opening of the Prostate Cancer Treatment Center (PCTC). Since pioneering prostate brachytherapy in 1985 and the Seattle Prostate Institute in 1997, Dr. Peter Grimm has treated over 3,500 patients. He and his colleagues, Dr. Blasko and Dr. Sylvester, have treated over 10,000 patients and trained over 6,000 physicians, nurses and physicists. His interest in improving prostate cancer care has led to establishing the Prostate Cancer Treatment Center as a premier center for Prostate Seed Implantation.

In the News

Current PSA Screening Guidelines Reported by Dr. Peter Grimm for the King County Medical Society

Prostate cancer (PC) is the second leading cause of cancer-related mortality in men, with approximately 28,000 deaths per year. Screening for PC with the prostate-specific antigen (PSA) test carries some controversy, and patient questions arise about how to interpret the test results, as well as what can be done to mitigate the risk.

Dr. Grimm to Present at the American Brachytherapy Society Workshop in Chicago This Summer

Dr. Peter Grimm will present on multiple subjects, including: the latest techniques in Prostate Brachytherapy from the Prostate Cancer Treatment Center, the advantages of permanent seed implantation over High Dose Rate Brachytherapy, the advantages of preplanning seed implantation and the new advancement in Thin Seed technology.

European Study: PSA Screening Reduces Mortality Up to 31%

PSA screening has reduced prostate cancer mortality up to 31%, according to findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Important New Info Regarding Radical Prostatectomy Surgery

The most serious complications…appeared more often in men who underwent minimally invasive surgery.

Prostate Cancer Treatment Center Physicians First in the Country to Use New Thin Strand® Technology

Developed in cooperation with GE Oncura, Drs. John Sylvester and Peter Grimm presented this new device at this year's annual SPI conference in Seattle, WA. The initial results will be presented at the ASTRO medical convention 2009 in Chicago, IL.

Prostate Cancer Results Study Group Announces
Comparative Effectiveness of Prostate Cancer Treatments

Dr. Grimm, lead author, will present the outcomes this fall at ASTRO's 2009 annual meeting.

15-Year Results Show Excellent Disease Free Survival for Seed Implantation

Drs. Sylvester and Grimm, et al presented the results at the ASTRO 2009 and ASCO 2010 GU conventions.

Our Mission

PCTC strives to meet the highest standards of care for our patients through individual care, clinical research and the latest in advanced prostate cancer technology. We are dedicated to improving the quality of life and increasing better treatment outcomes in every patient we see. Please contact us to see how we can help you.